![The FDA Oncology has approved the first T cell receptor gene therapy for adults with metastatic synovial sarcoma – SITC](https://oncodaily.com/pub/uploads/2024/04/fda_approved.jpg)
Aug 4, 2024, 09:29
The FDA Oncology has approved the first T cell receptor gene therapy for adults with metastatic synovial sarcoma – SITC
Society for Immunotherapy of Cancer (SITC) shared on X:
“The FDA Oncology has approved the first T cell receptor gene therapy for adults with metastatic synovial sarcoma. This cutting-edge treatment is a significant advancement in cancer treatment. Learn more.”
Source: SITC/X